Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Exp Parasitol ; 156: 79-86, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26072200

RESUMEN

In the search of new alternatives for neurocysticercosis treatment, the cysticidal activity of organic extracts of Teloxys graveolens was evaluated. The in vitro activity of hexane, ethyl acetate and methanol extracts against Taenia crassiceps cysts was tested and the selectivity index relative to human fibroblasts was determined. Subsequently, the in vivo efficacy of the methanolic extract at doses of 200 and 500 mg/kg in the murine cysticercosis model was evaluated. The ultrastructural effects in vitro and in vivo of the methanolic extract were also investigated using scanning electron microscopy. Additionally, a bioassay-guided fractionation for the isolation of the cysticidal components was performed. Our in vitro findings revealed that all extracts exhibited good cysticidal activity with EC50 values from 44.8 to 67.1 µg/mL. Although the ethyl acetate and methanolic extracts displayed low cytotoxicity, the methanolic extract was the most selective. The methanolic extract also showed in vivo efficacy which was similar to that obtained with ABZ. Significant alterations were found on the germinal layer of the cysts, with a high accumulation of granules of glycogen and vacuoles. The bioguided fractionation of methanolic extract led to the isolation of three flavonoids: chrysin, pinocembrin and pinostrobin; among them, pinocembrin was the compound that displayed cysticidal activity. This is the first study which reveals that T. graveolens could be a potential source for cysticidal and non-toxic compounds.


Asunto(s)
Amaranthaceae/química , Cisticercosis/tratamiento farmacológico , Cysticercus/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Bioensayo , Cysticercus/ultraestructura , Femenino , Fibroblastos/efectos de los fármacos , Flavanonas/química , Flavanonas/aislamiento & purificación , Flavanonas/farmacología , Flavonoides/química , Flavonoides/aislamiento & purificación , Flavonoides/farmacología , Encía/citología , Humanos , Ratones , Ratones Endogámicos BALB C , Microscopía Electrónica de Transmisión , Componentes Aéreos de las Plantas/química , Extractos Vegetales/química , Extractos Vegetales/uso terapéutico , Extractos Vegetales/toxicidad
2.
Exp Parasitol ; 149: 1-6, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25500213

RESUMEN

In the search of new alternatives for neurocysticercosis treatment, Taenia crassiceps ORF strain cysticerci have been used instead of T. solium for in vitro studies. Up to date, the main criteria for the use of the murine cysticercosis model for drug efficacy evaluation have not been assessed. The aim of the present study was to evaluate the influence of two of the main variables related to the in vivo efficacy: the length of drug treatment and the starting time of treatment after experimental infection, using albendazole (ABZ) and praziquantel (PZQ) as test drugs. Additionally, the relationship between the number of cysts and the parasite weight was assessed. For the study, female BALB/c mice were experimentally infected with T. crassiceps cysts. Three different post-infection periods (10, 20 and 30 days) and three different lengths of treatment with ABZ or PZQ (10, 20 and 30 days) were selected. The efficacy of each treatment was evaluated by comparison with a control group. Our results show that for in vivo efficacy studies, the best time to start the drug treatment is 10 days post-infection and that a minimum of 20 days of treatment is required when ABZ or PZQ are used as positive control. Moreover, in this model the parasite weight can be used as a rapid tool to measure the in vivo drug activity.


Asunto(s)
Albendazol/uso terapéutico , Antihelmínticos/uso terapéutico , Cisticercosis/tratamiento farmacológico , Praziquantel/uso terapéutico , Albendazol/administración & dosificación , Animales , Antihelmínticos/administración & dosificación , Cisticercosis/parasitología , Cysticercus/efectos de los fármacos , Modelos Animales de Enfermedad , Esquema de Medicación , Evaluación Preclínica de Medicamentos , Femenino , Ratones , Ratones Endogámicos BALB C , Praziquantel/administración & dosificación , Factores de Tiempo
3.
Exp Parasitol ; 137: 14-20, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24309372

RESUMEN

The present study aimed to notify the history of albendazole sulphoxide (ALB-SO) and albendazole (ALBZ) efficacy against Taenia saginata cysticercus (Cysticercus bovis) parasitizing experimentally infected bovines. A total of 11 efficacy trials were performed between the years of 2002 and 2010. In order to perform these trials, animals were individually inoculated with 2×10(4) eggs of T. saginata in each study's day zero (D0). For every trial, a positive control group (untreated infected animals) and a negative control group (animals that were neither infected nor treated) were used. ALB-SO or ALB were administered in the different dosages, in different days of treatments. In a last study with this formulation, this active principle was administered orally, mixed with the mineral supplement, on the 60th DPI, in a dosage of 30mg/kg. In all trials, on the 100th DPI, all animals were euthanized and submitted to the sequenced slicing of 26 anatomical segments (fragments of approximately five millimeters) for the survey of T. saginata cysticercus. With the obtained results it is possible to verify that in the first trials, conducted in 2002, ALB-SO reached, independently of dosage and treatment scheme, efficacies superior to 98% (arithmetic means). The trials conducted in 2005 (2.5mg/kg on the 30th, 60th, and 90th DPI) obtained values of efficacy all inferior to 60%. In 2008, the trials with 2.5 and 7.7mg/kg demonstrated efficacy values inferior to 40%, for both dosages and treatment schemes (30th/60th/90th DPI and 60th DPI). When this formulation was administered orally on the dosage of 30mg/kg on the 60th DPI, the efficacy against T. saginata cysticercus reached 88.28%. ALB administered orally showed efficacy values of 0.0%, 29.88% and 28.64% in the dosages of 5, 10 and 15mg/kg, respectively, using the treatment schemes described above for each dosage. Based on the results of these trials, conducted in an eight year period (2002-2010) using the sequenced slicing method for evaluating the efficacy of the aforementioned formulations against T. saginata cysticercus, it is possible to observe that, amongst the few molecules used in the chemotherapic treatment against T. saginata larvae, ALB-SO, administered in varied routes, dosages and treatment schemes, the studies conducted in 2008, 2009, and 2010, have a low therapeutic efficacy against C. bovis in Brazil, while ALBZ had insignificant efficacy values against T. saginata larvae parasitizing experimentally infected bovines. However, future studies using molecular biology will be necessary to assess whether the difference on the efficacy of the ALB-SO can be related to strain or another specific factor.


Asunto(s)
Albendazol/análogos & derivados , Anticestodos/uso terapéutico , Enfermedades de los Bovinos/tratamiento farmacológico , Cisticercosis/veterinaria , Taenia saginata/efectos de los fármacos , Administración Oral , Albendazol/administración & dosificación , Albendazol/farmacología , Albendazol/uso terapéutico , Animales , Anticestodos/administración & dosificación , Anticestodos/farmacología , Bovinos , Enfermedades de los Bovinos/parasitología , Cisticercosis/tratamiento farmacológico , Cisticercosis/parasitología , Cysticercus/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Humanos , Inyecciones Subcutáneas/veterinaria
4.
Parasite Immunol ; 28(12): 667-74, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17096646

RESUMEN

The effects of progesterone on castrated mice of both sexes infected with Taenia crassiceps cysticerci were studied. Gonadectomy and treatment with progesterone before infection decreased parasite loads by 100% compared with intact uninfected mice. mRNA levels of IFN-gamma and IL-2 (typically associated to Th1-like profiles) were markedly decreased in infected gonadectomized (Gx) mice, whereas progesterone treatment of infected Gx mice did not affected its expression. mRNA levels of IL-4, and IL-10 (typically associated with Th2-like profiles) were reduced by gonadectomy, whereas restitution with progesterone did not affected this pattern in infected Gx progesterone-treated mice. Infection markedly induced expression of progesterone receptor isoform A in splenocytes of Gx mice (5-fold), whereas isoform B had no changes. Progesterone metabolism to dehydroepiandrosterone (DHEA) in Gx animals was increased 3-fold only in infected progesterone-treated uninfecteds of both sexes, but was not detectable in infected Gx progesterone-treated mice. Conversely, DHEA levels increased 100-fold in infected Gx progesterone-treated mice. However, androgen receptor expression in splenocytes of male mice showed a reduction by gonadectomy, and by infection, whereas in females AR expression showed no changes in the different mouse groups. These results suggest that progesterone, through its metabolism to DHEA, negatively affects the establishment, growth, and reproduction of Taenia crassiceps, by a mechanism that does not implicate a classic genomic pathway involving a nuclear androgen receptor.


Asunto(s)
Cisticercosis/inmunología , Orquiectomía , Ovariectomía , Progesterona/uso terapéutico , Progestinas/uso terapéutico , Adyuvantes Inmunológicos/metabolismo , Adyuvantes Inmunológicos/farmacología , Animales , Cisticercosis/parasitología , Cysticercus/efectos de los fármacos , Deshidroepiandrosterona/metabolismo , Deshidroepiandrosterona/farmacología , Femenino , Masculino , Ratones , Ratones Endogámicos BALB C , Progesterona/administración & dosificación , Progesterona/metabolismo , Progestinas/administración & dosificación , Progestinas/metabolismo , Taenia/efectos de los fármacos , Taenia/crecimiento & desarrollo , Resultado del Tratamiento
6.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 17(12): 742-4, 1997 Dec.
Artículo en Chino | MEDLINE | ID: mdl-10322824

RESUMEN

OBJECTIVE: To observe the effect of Mienangling (MNL) in treating cysticercus cellulosae in vitro. METHODS: The changes of cysticercus cellulosae treated in vitro with the MNL extracts, praziquantel (PQT) and albendazole (ALB) were studied under the transmission and scanning electron microscopes. RESULTS: Under the scanning electron microscope, the authors can see that all of the cysticercus's scoleces did not grow in the MNL and PQT groups, cyst walls shrivelled, tegument's ectoplasts were damaged, microtriches's ultrastructures were not clear or exfoliated, some corpuscular matter densely was distributed in the surface; 46.7% of cysticercus cellulosaes in the ALB group had been excystated, the rostellar hooks of rostella developed normally, four sucker's surface wrer hollow, the necks were eroded, and grooves of sonite disappeared. Under the transmission electron microscope, we can see that the tegument, basement membrane, muscular layer and parenchyma in the groups of MNL and PQT were all clearly damaged, but the harmful effect of MNL to parenchyma's nerve cords is more serious than the PQT. The damage of all layers of the cysticercus cellulosae in the ALB group is smaller in degree than the MNL and the PQT. CONCLUSION: The MNL has marked damaging effect to cysticercus cellulosae.


Asunto(s)
Anticestodos/farmacología , Cysticercus/ultraestructura , Medicamentos Herbarios Chinos/farmacología , Albendazol/farmacología , Animales , Cysticercus/efectos de los fármacos , Microscopía Electrónica , Microscopía Electrónica de Rastreo , Praziquantel/farmacología
7.
Int J Parasitol ; 25(12): 1443-50, 1995 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8719956

RESUMEN

Cysticercosis, a disease of economic and public health importance, is caused by Cysticercus cellulosae, the metacestode stage of Taenia solium. Experimental induction of cysticercosis was achieved in young pigs by feeding an optimum dose of 20,000 T. solium (Indian strain) eggs after immunosuppression, to assess the effect of albendazole and development of the immune response to cysticercus antigens before and after treatment. Histopathological studies revealed the presence of cysticerei in liver, lungs and muscles. Treatment with albendazole at 15 mg kg-1 body weight daily for 30 days starting from day 0 or 15 days post-infection resulted in 100% cure rates. Increases in antibody titre to crude soluble extract and a Sephadek G-200 purified antigenic fraction of Cysticercus cellulosae were found on days 25, 40 and 55 post-infection in untreated pigs and those in which treatment started on day 15 post-infection, whereas no increase in antibody response was observed in pigs in which treatment started on day 0.


Asunto(s)
Albendazol/uso terapéutico , Antihelmínticos/uso terapéutico , Cisticercosis/tratamiento farmacológico , Cysticercus/efectos de los fármacos , Animales , Anticuerpos Antihelmínticos/sangre , Antígenos Helmínticos , Cisticercosis/inmunología , Cisticercosis/parasitología , Cysticercus/inmunología , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Cinética , Hígado/parasitología , Hígado/patología , Parasitosis Hepáticas/tratamiento farmacológico , Parasitosis Hepáticas/inmunología , Parasitosis Hepáticas/parasitología , Porcinos
8.
Zhongguo Zhong Yao Za Zhi ; 16(5): 302-3, 320, 1991 May.
Artículo en Chino | MEDLINE | ID: mdl-1781901

RESUMEN

Putting the alcohol-extract from scorpion in the ordinary aqueous solution of 15% pork bile and having it cultured at the temperature of 37 degrees C have proved for the first time that in contrast with the chemical albendazole, Scorpion has a conspicuous effect on the external killing of the cysticercus cellulosae, The action of killing cysticercus cellulosae has almost nothing to do with the difference of processed products or of the parts used in medicine.


Asunto(s)
Cysticercus/efectos de los fármacos , Materia Medica/farmacología , Escorpiones , Animales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA